Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04678245 · ClinicalTrials.gov registry record · NA
Network Intervention to Prevent Vaping
A NA study of Vaping and Preventive Psychiatry, sponsored by University of Rochester.
- Active
- Registry status
- NA
- Development phase
- 3,840
- Enrollment target
- 1
- Study location
NCT04678245: Active NA study of Vaping and Preventive Psychiatry, sponsored by University of Rochester.
NCT04678245 is a NA study of Vaping and Preventive Psychiatry that is active but no longer recruiting, run by University of Rochester. The registered enrollment target is 3,840 participants, above the 547-participant average among 18 other Vaping trials with a reported enrollment target (602% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04678245, a NA study of Vaping and Preventive Psychiatry, is active but no longer recruiting, sponsored by University of Rochester.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 3,840 participants
- Enrollment target
- 1
- Study location
Study Summary
Rates of adolescent vaping are increasing rapidly. Current high school student use of electronic vaping products (EVPs) rose from 1.5% in 2011 to 20.8% in 2018 - an increase from 220,000 to 3.05 million adolescent users. Effective, school-based interventions are urgently needed to protect adolescents from initiating or continuing use of electronic vaping products (EVPs). This study leverages a state-supported prevention initiative to test the effectiveness of a promising intervention that trains 8th-9th grade student peer leaders to deliver school-wide vaping prevention campaigns with ongoing adult mentoring. If study hypotheses are supported, the study will provide the first evidence of a school-based preventive intervention that reduces adolescent vaping behaviors, as well as insight into how peer communications can be harnessed to prevent vaping.
Primary Outcome
Self reported use of any electronic vaping product during the past 30 days, assessed using participant questionnaire. The outcome is reported as the number of participants reporting any vaping within the previous 30 days.
Conditions Studied
Interventions
- BEHAVIORAL Above the Influence-Vaping (ATI-V)
Study Locations (1)
New York
- University of Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,840 participants |
| Start Date | 2020-09-01 |
| Est. Completion | 2025-10-04 |
| Phase | NA |
What the registry record for NCT04678245 still lists
NCT04678245 is an interventional study that assigns participants to a tested intervention. Its 3,840 participants enrollment target places it among the larger protocols in the corpus, above the 547-participant average among 18 other Vaping trials with a reported enrollment target (602% higher).
The record links to 3 conditions, with Vaping appearing as the primary indexed condition, and to 1 intervention - of which Above the Influence-Vaping (ATI-V) is the first listed.
NCT04678245 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT04678245 about?
NCT04678245 is a clinical study titled "Network Intervention to Prevent Vaping". Rates of adolescent vaping are increasing rapidly. Current high school student use of electronic vaping products (EVPs) rose from 1.5% in 2011 to 20.8% in 2018 - an increase from 220,000 to 3.05 million adolescent users. Effective, school-based interventions are urgently needed to protect adolescent...
What is the current status of trial NCT04678245?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 3,840 participants. The study started on 2020-09-01. Estimated completion is 2025-10-04.
What conditions does trial NCT04678245 study?
This clinical trial studies the following conditions: Vaping, Preventive Psychiatry, Social Networking.
What interventions are being tested in trial NCT04678245?
The interventions under investigation include: Above the Influence-Vaping (ATI-V) (BEHAVIORAL).
Who is sponsoring clinical trial NCT04678245?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04678245 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Vaping
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04678245's enrollment target sits among peer trials
3,840 1st of 18 higher than 18 of 18 other Vaping trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Vaping trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Non-invasive Vagus Nerve Stimulation (nVNS) and Cognition in Young Adult Vapers - A Pilot Study
RECRUITING · NA
-
Perceived Effectiveness of Vaping Prevention Ads Among Adolescents and Young Adults
RECRUITING · NA
-
Secondhand Effects of Hookah (i.e., Waterpipe) Smoke and Aerosol
RECRUITING · NA
-
Behavioral Intervention for Youth to Promote Vaping Cessation
RECRUITING · NA
-
Implementing an Adolescent and Young Adult (AYA) mHealth Vaping Cessation Program Into Oncology Clinics
RECRUITING · NA
-
PACE Vape Messaging Study
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07087613 · 3,850 participants
Deep Learning Detection of Pulmonary Hypertension and Low Ejection Fraction Via Digital Stethoscope and 3-Lead ECG
- NCT04573660 · 3,784 participants
Abbott Vascular Medical Device Registry
- NCT05919342 · 3,904 participants · NA
Screening for earlY Heart Failure Diagnosis and Management in Primary Care or at HOme Using Natriuretic Peptides and echocardiographY "SYMPHONY-HF"
- NCT03936335 · 3,930 participants
An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis (AD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI